In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GE Med Systems, Amersham enter PET agreement

Executive Summary

GE Medical Systems and Amersham Health (formerly Nycomed Amersham Imaging; diagnostic imaging and therapeutics) have agreed to jointly develop positron emission tomography (PET)-based molecular diagnostic imaging technologies and systems to detect early symptoms for a range of diseases including cancer and Parkinson's disease.
Deal Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register